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ABSTRACT
Eliminating Opioid Use in the
Treatment of Chronic
Lower-Back Pain
Tyler Hobbs
College of Nursing, BYU
Master of Science
Opioid use is an epidemic in the US costing millions annually. Chronic lower-back pain
(CLBP) affects people world-wide and is frequently treated with opioids long-term. Long-term
opioid use leads to negative health related consequences, increased risk for depression, negative
unintended opioid related side-effects, overdose, and death. The purpose of this article is
threefold: 1) to educate PCP on the complexities of CP and negative implications of opioid
treatment for CLBP while illuminating the benefits of non-opioid management, 2) to review nonopioid treatment methods for CLBP to eliminate opioids, and 3) to construct feasible options for
treating CLBP without opioids.
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Eliminating Opioid Use in Treatment of Chronic Lower Back Pain
Chronic pain (CP) effected over 36 million Americans in 2016. People suffering from
CP are often treated with opioids either exclusively or excessively (Kuo, Raji, Chen, Hasan, &
Goodwin, 2016). CP is pain persisting longer than the normal recovery time of an acute injury;
it is often defined as pain lasting longer than 90 days (Falope & Appel, 2015). CP is often
treated with opioids which can cause problems. Between 1999 and 2014 over 160,000
Americans lost their lives related to opioid abuse. In 2013, nearly 2 million Americans were
either addicted to or abused opioid prescriptions, and opioid use has been increasing each year.
(Dowell, Haegerich, & Chou, 2016). Thus, opioid overuse is an epidemic plaguing the US for
several decades.
Originally opioids were intended to treat acute pain. They were never intended to be
used chronically. In the last 100 years, clinicians’ approach to CP management has changed.
Decades ago, CP treatment with opioid was judicious and sparing. However, opioid
prescriptions for Medicare part D recipients increased from 4.62% in 2007 to 7.35% in 2012 .
Data from 2012 show large variance in individual states from a low of 2.84% in New York to a
high 10.93% in Utah (Kuo et al., 2016). In addition, opioid/sedative co-prescriptions occurred in
over 36% of CP visits to the primary care provider (PCP) (Larochelle, Zhang, Ross-Degnan, &
Wharam, 2015). Soporific medications (benzodiazepines, hypnotics, and sleeping aids)
prescribed with an opioid increases the risk of opioid-related death. As noted, opioid
prescription trends have been moving in the wrong direction. Moving forward, clinicians need to
adjust their management of CP by using treatment strategies eliminating opioid medications.
Chronic Lower Back Pain
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CP results from a variety of etiologies. Consequently, this paper focuses on chronic low
back pain (CLBP) because it is one of the most common causes of CP. It is estimated between
60% to 80% of adults will have lower back pain at some point in their lives, and 30% of those
effected will have pain lasting longer than one year (Falope & Appel, 2015; Gordon & Bloxham,
2016). In summation, between 58 and 78 million people in the US suffer from CLBP daily.
CLBP is commonly treated with long-term opioid therapy, which can cause increased sensitivity
to pain, decreased physical activity, depression, opioid tolerance, and opioid related death.
Proper management of CLBP is imperative to ensure patients experience the best possible
quality of life. Non-opioid options in treatment will facilitate a shift in this epidemic. The
purpose of this article is threefold: 1) to educate PCP on the complexities of CP and negative
implications of opioid treatment for CLBP while illuminating the benefits of non-opioid
management, 2) to review non-opioid treatment methods for CLBP to eliminate opioids, and 3)
to construct feasible options for treating CLBP without opioids.
Problems Associated with CLBP
CLBP is a complex problem and requires treatment regimens ensuring patients suffering
from CLBP have the best possible quality of life. There are many factors making CLBP
complex. Common opioid-related problems associated with CLBP include opioid-induced
hyperalgesia (OIH), opioid tolerance, side-effects and adverse drug reactions to opioids, and
depression; other problems are decreased physical activity, quantifying pain, and type of CLBP.
Opioid Induced Hyperalgesia and Opioid Tolerance
Opioids have two significant side-effects warranting discussion: Opioid-induced
hyperalgesia (OIH) and opioid tolerance. The chronic use of opioids can lead to OIH, which is a
pain response non-congruent with the stimulus. This occurs because of the body’s adaptive
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response to opioids. The use of opioids can cause an increase in pain receptors resulting in an
increased stimulus or hyperalgesic affect (Bannister, 2015). For example, if a patient has OIH
and fractures their ankle, their pain may be much more intense than expected. Opioids, which
would normally work, have little effect on their pain perception.
Chronic opioid use leads to tolerance, meaning higher doses of opioids are required to
achieve the same effect, contributing to OIH. Tolerance to opioids occurs faster than the body’s
ability to adjust to the cardio/respiratory depressive side-effects resulting in an increased risk of
overdose. Opioid tolerance occurs when mu opioid receptors (the site opioids bind for analgesic
properties) become down regulated by receptor endocytosis. This may occur acutely, within
minutes of ingestion, and/or chronically over time (Dang & Christie, 2012). This may lead to
higher pain ratings and often an increase in the opioid dose .
Negative Implications of Opioids
There are many side-effects of opioids (see table 1). The top three most common and
concerning side-effects are respiratory and circulatory depression, chemical dependence, and
constipation (Kuo et al., 2016). Patients taking opioids have an increased risk of overdose
because of their addictive nature and risk of depression of vital bodily functions, as these are
side-effects of the medications. Overdose occurs when too much opioid is taken or by
combining with other depressive medications, especially benzodiazepines, resulting in decreased
circulatory and respiratory drive depriving the body of oxygen.
Decreased Physical Activity
Adequate treatment of CLBP is paramount because of the decreased quality of life related
to inadequate treatment. Under treatment leads to depression and decreased physical activity
while overtreatment with opioids leads to detrimental opioid-related adverse effects (Holtzman
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& Beggs, 2013). Patients with CLBP attempt to minimize pain by avoiding painful stimulus,
which can be exacerbated by physical activity. Thus, patients avoid activity because of the
consequential pain. This inactivity causes muscles and bones to weaken and results in increased
pain perception in the future. It also leads to a sedentary lifestyle.
Depression
Pain is influenced by perception, body chemistry, emotions, and coping mechanisms
(Falope & Appel, 2015; & Mehalick, 2014). CLBP frequently is accompanied and influenced by
depression. Tetsunaga, Tetsunaga , Tanaka, & Ozaki (2015) noted greater than 75% of patients
with CLBP were classified as depressed, and nearly 40% of CLBP patients with depression had
severe depression. Studies have shown opioid use is associated with depression; patients taking
opioids were more likely to have depressive symptoms than those not taking opioids with similar
pain ratings (Falope & Appel, 2015; Mehalick, 2014; Testunaga et al., 2015). Depression can
lead to increase pain perception because of the psychological components of coping mechanisms
and emotions (Goesling et al., 2015). A frequent query regarding this subject is, what causes the
depression? Is it the opioids or the chronic pain? The answer is both. CP is linked to depression,
and depression is listed on the side-effects of opioids. Therefore, depression is commonly seen in
people with CLBP treated with opioids.
Quantifying Pain
Another obstacle in properly managing CLBP are the tools used by PCPs to measure
pain. There are many pain measurement tools; however, each tool is subjective. Every patient’s
interpretation, perception, pain, and history are different. This subjectivity varies greatly making
it difficult to measure pain. In addition, patients suffering from opioid addiction may inflate
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their pain score to obtain fuel for their addiction. Because of subjective pain measurement, PCPs
have no choice but to take patients at their word and treat accordingly.
Non-Opioid Treatments Options for CLBP
There are several non-opioid treatment options for CLBP, these may include non-opioid
medication, combination medications, physical activity (exercise, yoga, and physical therapy),
acupuncture, and spinal cord stimulation.
Pharmacologic Management of CLBP
CLBP is difficult to manage because it can have neuropathic or nociceptive pain or both.
Neuropathic is pain caused by disease or lesions affecting a nerve in the peripheral or central
nervous system. Nociceptive pain results from stimulation of nociceptors in tissues caused by
trauma or disease (Falope & Appel, 2015). Understanding the pathophysiology of CLBP is
important when choosing an appropriate treatment regimen for a specific patient.
It is rare to manage CLBP without medications. If CLBP has both neuropathic and
nociceptive components, monotherapy is ineffective. There are several non-opioid medications
effective for CLBP. These medications include acetaminophen, non-steroidal anti-inflammatory
drugs (NSAIDs), muscle relaxants, antidepressants, and anticonvulsants.
A recent study comparing opioid verses non-opioid medications treating chronic back
pain and hip or knee osteoarthritis revealed non-opioid treatment is more effective. The study
showed better pain rating scores as well as lower adverse drug reactions with non-opioids when
compared with opioids (Krebs et al., 2018). This is important because this supports using nonopioid treatments and will help the complications associated with opioid and will result in better
patient outcomes.
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Acetaminophen. Acetaminophen is a mild analgesic which has antipyretic properties. It
decreases the production of prostaglandins, thereby decreasing pain. It has no influence on
neuropathic pain and no anti-inflammatory properties, but it does help with nociceptive pain
(Falope & Appel, 2015). Acetaminophen is effective in treating mild CLBP. For severe pain,
Acetaminophen can be used with other medications and together can effectively treat severe
pain. Because acetaminophen works differently than other non-opioid pain medications, the
effect of acetaminophen combined other medications is much greater than either medication used
separately. In addition, some combinations have a synergistic effect making their combined
effect extremely efficacious.
NSAIDs. NSAIDs inhibit either COX-1, COX-2, or both receptors and decrease
prostaglandin synthesis. NSAIDs are used as an anti-inflammatory medication. Their antiinflammatory attributes are valuable for pain relief and have less side-effects than steroids.
However, they do have side-effects that merit discussion. COX-1 inhibition prevents the
stomach from producing gastroprotective prostaglandins, causes thinning of the stomach lining,
and increases stomach acid. COX-2 prevents the synthesis of inflammatory prostaglandins and
decreases the ability of platelets to adhere to one another (Falope, & Appel 2015).
NSAIDS place the patient at risk for gastric ulcers and associated bleeding. NSAIDS
have anti-inflammatory properties which decrease nociceptive pain, but they do not help with
neuropathic pain unless directly related to inflammation. When using NSAIDs long-term, it is
best to prescribe a selective COX-2 medication, such as Celebrex, to avoid stomach
complications, or use a non-selective medication, such as Ibuprofen, in conjunction with
medications with gastro-protective attributes, such as Carafate or Omeprazole.
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A recent study compared NSAIDs and tramadol. The study revealed NSAIDs were as
effective as tramadol in pain relief and better than tramadol when there was an inflammatory
component (Falope & Appel, 2015). NSAIDS are a crucial tool in the treatment of CLBP and
combine efficiently with other non-opioid medications. PCPs can treat CLBP with NSAIDs in
patients with mild to severe pain especially when inflammation is present. Patients with mild
pain may only need an NSAID, but severe pain may need additional medications .
Antidepressants. Antidepressants can be used to decrease neuropathic pain in both the
central nervous system and peripheral nervous system independent of its anti-depressive
properties. Studies testing antidepressants for the treatment of neuropathic pain have conflicting
results. Not all antidepressants aid in decreasing neuropathic pain, but serotonin norepinephrine
reuptake inhibitors (SNRIs) and tricyclic antidepressants (TCAs) have shown to decrease
neuropathic pain and are used as a pain adjunct (Falope & Appel, 2015; Williamson, Sagman,
Bruins, Boulay, & Schacht, 2014).
Serotonin-norepinephrine reuptake inhibitors (SNRIs). Like TCAs, SNRIs have
neuropathic analgesic and anti-depressive qualities. These medications cause an increase in
serotonin and norepinephrine at the neuronal junction causing an inhibitory effect resulting in
decreased nerve transmission of pain signals (Mehalick, 2014). There have been several studies
showing a significant decrease in pain with SNRIs (Falope & Appel, 2015; Skljarevski et al.,
2010; Williamson et al., 2013). SNRIs should be used as an adjunct with other medications,
such as NSAIDs and Acetaminophen. SNRIs side-effects are tolerated better than TCAs with
similar analgesic results. SNRIs should be used first-line anti-depressants for pain adjunct
targeting the neuropathic component of CLBP (Falope & Appel, 2015).
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Tricyclic antidepressants (TCAs). TCAs decrease neuropathic pain, in addition to their
antidepressant effects. TCAs inhibit several different serotonergic areas in the body (McCleane,
2003). Ferjan and Lipnik-Stangelj (2013) isolated mast cells in rats to determine what effects
TCAs have on mast cell secretion of serotonin. They determined TCAs inhibit serotonin
secretion and reuptake suggesting these medications produce pain relieving effects both
peripherally and centrally. Several types of TCAs were tested. The most effective was
Clomipramine. TCAs can be used with a NSAID and Acetaminophen, thus targeting both
nociceptive and neuropathic pain and successfully treat moderate to severe CLBP. Studies show
TCAs are effective for neuropathic pain, but some side-effects are intolerable for some patients.
These side-effects include nausea, vomiting, weight gain, decreased libido, sleepiness, vision
changes, and confusion.
Anticonvulsants. Anticonvulsants are used as a pain adjunct for neuropathic pain.
Anticonvulsants decrease pain by targeting calcium channels on nerves inhibiting painful nerve
impulses (Mehalick, 2014). Anticonvulsant drugs vary in mechanism of action and location.
For example, Carbamazepine and Phenytoin work on different sodium channels, and Koseride
act on strych-nine-sensitive glycine channels (McCleane, 2003). Understanding the mechanism
of action is important because it allows PCPs to change medications within the same class but
with a different mechanism of action.
Studies have shown anticonvulsants are effective in treating CLBP. Some of their sideeffects include somnolence, edema, weight gain, dry mouth, constipation, and vision changes.
Anticonvulsants are not used for monotherapy, and Lyrica and Neurontin have the lowest sideeffect profile (Falope & Appel, 2015). Anticonvulsants have helped many people suffering with
CLBP deal with the pain and experience a better quality of life.
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Muscle relaxants. Muscle relaxants can be used as an adjunct for CLBP management.
Baclofen has a favorable side-effect profile. It decreases muscle spasms, helps induce sleep, and
reduces pain. Muscle relaxants are GABA-s receptors agonists, which inhibit painful
neuropathic impulses (McCleane, 2003). The last few medications reviewed (antidepressants,
anticonvulsants, and muscle relaxers) all cause somnolence and combining these together can
cause respiratory depression similar to opioids. They should not be combined with sleeping aids
or alcohol. The soporific effects of combined medications are a critical consideration in treating
CLBP and should be monitored closely and prescribed with caution. In addition, they should not
be taken with opioids.
Combination medication therapy. Since most medications do not cover both
neuropathic and nociceptive pain pathways, it is effective to use combination medication
therapy. CLBP stems from many etiologies, and pain and characteristics vary immensely. Each
medication has its place and can be used in monotherapy for minor CLBP or in combination for
more moderate to severe CLBP. One drug combination is Lyrica and Celebrex. These
medications together perform in a synergistic manner and provide significantly better pain
control than monotherapy (Falope & Appel, 2015). Another synergistic combination is
Acetaminophen, Celebrex, Amitriptyline and Lyrica for severe CLBP pain. Combining
Amitriptyline and Lyrica should be used with caution because each can cause dizziness and
somnolence side-effects.
Non-Pharmacologic Management of CLBP
Physical activity (PA) including physical therapy (PT), exercise therapy, and yoga is
possibly the most important tool PCPs can utilize to improve their patients’ quality of life.
Patients suffering from CLBP commonly think rest is best for healing. However, PA has positive
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implications for patients suffering from CLBP. PA increases circulation, helping nutrients enter
the damaged area, facilitates removal of waste, improves healing, decreases pain, promotes
muscle growth, and increases strength and flexibility. Increasing strength and flexibility of the
trunk helps strengthen the body’s core improving musculoskeletal stability. This strength and
stability help to prevent future injury, improve disability, and decrease pain (Gordon & Bloxham,
2016). All varieties of PA mentioned in the following sections have similar benefits listed above
in addition to improved strength or flexibility.
Physical Therapy
PT has been utilized in healthcare since the 1800s. Studies show PT decreases pain,
improves healing, and improves disability. Combining PT with medications helps patients with
CLBP tolerate PT, improves performance, and decrease pain (Morris, Pellow, Solomon, TseleTebakang, & Solomon, 2016; Onac, Moldovan, Onac, Igna, & Pop, 2012). PT is well
established and is used because it has all the benefits of PA previously listed. PT is a short-term
therapy limited by insurance companies. Patients with CLBP should be encouraged to continue
a similar active routine after their allotted PT visits are extinguished .
Exercise Therapy and Yoga
Exercise therapy is a great way to get the benefits from PA. PCPs should encourage their
patients to start an exercise program incorporating things they enjoy. If patients are unfamiliar
with exercise, PCP’s can refer to either a personal trainer or physical therapist to help patients
establish a simple exercise routine. Exercise therapy is inexpensive, convenient, and shares the
benefits of PA previously listed. It allows patients to strengthen weakened areas resulting in
increased strength and stability thereby decreasing pain. Gordon & Bloxham (2016) conducted a
systematic review of the effects of muscle strengthening exercise, aerobics, and flexibility
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exercise and found they resulted in decreased disability and pain in patients suffering from
CLBP. Some patients may not like exercise therapy or aerobic type activity. Yoga is another
option PCPs can use to promote PA. Studies have shown yoga produces effective results for
CLBP by reducing pain and disability and increasing flexibility (Holtzman & Beggs, 2013).
Most Important Intervention
There has been a plethora of research all reaching the same conclusion. PA is one of the
most important and efficacious interventions for CLBP. PA enables continual improvement of
CLBP. However, PA is underutilized because of lack of knowledge; therefore, it is crucial to
educate patients and providers on the importance of PA in treating CLBP. PA is counterintuitive
to patients and does not result in immediate pain control. For this reason, patients may be noncompliant with PA. Therefore, education should facilitate breaking down this barrier, and
medications can enable patients to tolerate PA in order to further improve their outcome.
Spinal Cord Stimulation
Spinal Cord Stimulation (SCS) is a surgical procedure introduced in the 1960s and can
help with severe cases of CLBP that do not respond to treatment. SCS has several benefits,
including significant analgesic properties, reduction or elimination of opioid use, long-term
decreased health care expenditures, and improved quality of life (Grider et al., 2016).
Some patients with intractable CLBP have achieved 50% reduction in their pain through
SCS. Pain reduction can range from 16%-95%, and the surgery has less risks and better longterm outcomes than most back surgeries (Sumner & Lofland, 2014). Recent studies determined
SCS works for failed back surgery syndrome, which is significant pain that persists after back
surgery and healing. These studies were also reviewed by the National Institute for Health and
Care Excellence (NICE) in the United Kingdom. “NICE recommends SCS as a treatment for
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patients suffering from refractory chronic neuropathic conditions, including chronic low back
pain” (Grider et al., 2016, p. E34).
One study compared traditional SCS to high frequency SCS (HFSCS). The traditional
SCS group had 81 participants and showed 55% reduction in pain both short-term (less than 12
months) and long-term (greater than 12 months) compared to the HFSCS group with 90
participants and an 80% reduction in pain both short-term and long-term (Grider et al., 2016).
SCS is a valuable tool with potential to transform the worst cases of CLBP from people who are
opioid dependent, disabled, and live a sedentary life-style to people who take non-opioids with
increased mobility, decreased pain, and better quality of life. SCS allows patients to incorporate
PA into their treatment regimen where it may not have been an option prior to the procedure.
Acupuncture
Acupuncture has many positive results and can be used synergistically in combination
with other interventions. Acupuncture has existed for over 8000 years; however, it is a topic of
controversy in western medicine and frequently a target of skepticism. A recent RCT comparing
two groups; one that participated in exercise and auricular acupuncture the other group that
participated only in exercise. Both groups showed improvements; however, the combined
auricular acupuncture and exercise group had larger statistically significant improvements in
mobility, decreased disability, and decreased pain than the exercise group alone. (Hunter et al.,
2012).
A meta-analysis was conducted with 17,922 studies involving acupuncture for treatment
of many different CP conditions including CLBP, osteoarthritis, migraine and tension headaches,
and non-specific musculoskeletal pain (Vickers, Cronin, Maschino, Lewith, & MacPherson,
2012). Vickers et al. (2012) determined acupuncture is more than “sham acupuncture” (p. 7). It
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works consistently reducing pain and disability while improving the quality of life for those
treated. Another study revealed six benefits of acupuncture: decreased pain, enhanced physical
mobility, improved energy levels, relaxation, psychological benefits, and decreased medication
use (Hopton, Thomas, & MacPherson, 2013). Acupuncture works synergistically with PA and
medications to treat patients with CLBP.
Barriers to acupuncture. Numerous studies have shown acupuncture has merit in
treating a variety of afflictions (Hopton et al., 2013; Hunter et al., 2012; Vickers et al., 2012).
Hopton et al. (2013) focused on patient perceptions of acupuncture to identify benefits and
barriers, which included needle discomfort, temporary increase of pain, financial concerns, and
pressure to continue treatment. Without foreknowledge and clear expectations, patients may
experience these barriers and stop acupuncture prior to receiving the benefits.
Overcoming barriers. For some, acupuncture took the place of opioid pre-medication
prior to PA, and for others, acupuncture resulted in an overall decrease in reliance on and use of
opioids. Acupuncture participants first noticed an increased ability to perform physical functions
resulting from a decrease in painful stimuli. They could focus more on their abilities rather than
their disability. This empowered them to add exercise and active hobbies, enhancing their overall
health, quality of life, and pain management (Hopton et al., 2013.) Acupuncture is efficacious
and its longevity of existence originating in ancient China thousands of years ago speaks to this.
The most effective tool used to break-down barriers was a relationship between the patient and
acupuncturist, who educated the patient about expectations and empowered the patient to be
proactive in treatment (Hopton et al., 2013).
Implications for Practice
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Non-opioid treatment of CLBP begins with clear expectations, honesty, and education.
PCPs need to be straightforward with patients, so they can be prepared for the process.
Treatment should be centered on the patient’s goals; however, if the patient and the PCP’s goals
are non-congruent, communication and education are the tools needed to get both parties’ goals
aligned. In addition, targeting the correct pain pathways (neuropathic and nociceptive) for each
patient is an important consideration. Patients need to understand there is no cure for CLBP,
they will still have some back pain, may not see immediate results, and treatment requires
consistent hard work. The foundation for successful non-opioid treatment for CLBP is PA.
There are several ways a patient can participate in PA. Since each patient is unique, they should
pick an activity they enjoy that suits their situation. PA strengthens their core resulting in a
stronger more stable back and decreased disability and pain. Other treatment modalities can
enhance and enable patients to participate in their chosen form of PA. Acupuncture is a one way
to help decrease CLBP and enable a patient to participate in PA. NSAIDs combined with
Acetaminophen and Duloxetine or Lyrica will decrease pain and help patients tolerate PA. If
these non-opioid approaches are not tolerated, SCS implantation is an effective way to
significantly decrease pain to a level that PA can be tolerated.
Conclusion
CLBP is a monumental problem costing the United States millions of dollars annually.
Furthermore, PCPs are treating patients with opioids for CP without giving patients all the
information. It takes much less time to prescribe an opioid than spend the time needed educating
and motivating a patient on the negative implications of chronic opioid use and the benefits of
PA. Studies show long-term treatment with opioids causes tolerance and OIH, and patients who
take opioids long term rate their pain scores higher, have addiction issues, decreased PA,
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depression, and experience the side-effects of opioids (Bannister, 2015; Dang & Christie, 2012;
Falope & Appel, 2015; Goesling et al., 2015; Gordon & Bloxham, 2016). Patients need to be
aware that treatment with opioids long-term masks pain initially but results in no long-term
benefits. In addition, treatment with opioids does not appear to have better outcomes in any facet
of treatment of CLBP. According to Krebs et al. (2018) non-opioid treatment had better pain
management at three, nine, and twelve months than when treating with opioids. With the
addition of non-pharmacologic treatment, such as acupuncture and PA, patient outcomes would
improve more than with pharmacological interventions alone.
Patients need education on the benefits of PA. PA can enable a patient to be free from
opioid dependence and opioid related health implications. PCPs need to empower patients with
tools that help patients tolerate PA and imbue their patients with knowledge and motivation.
PCPs need to teach patients how non-opioid treatment for CLBP can provide them with
decreased pain, increased mobility, and better quality of life.
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Appendix

Table 1
Side-Effects of Opioids
Common Side-Effects
Dizziness
Somnolence
Nausea and vomiting
Hyperhidrosis
Flushing
Xerostomia
Pruritus
Dysphoria/ Euphoria
Headache
Constipation
Loss of appetite
Rash
Insomnia
Anxiety and agitation
Muscle spasm
Depression
Abdominal cramping
Vision changes
Fever
Confusion

Serious Side-Effects
Respiratory depression
Circulatory depression
Hypotension
Increased intra-cranial pressure
Seizures
Bradycardia
Paralytic ileus
Biliary spasm
Hypersensitivity reaction
Anaphylaxis
Adrenal insufficiency
Opioid-induced androgen deficiency
Dependency
Risk for abuse
Withdrawal symptoms if stopped abruptly
Addiction
Dyspnea
Syncope
Shock
Death

Note. Adapted from Epocrates Drug Guide, (Ehrlich, Baldor, & Domino 2018).
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